Kaken Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Kaken Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Kaken Pharmaceutical Co Ltd Strategy Report
- Understand Kaken Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Kaken Pharmaceutical Co Ltd (Kaken) is a specialty pharmaceutical company that conducts research and development of drugs, agrochemicals and medical equipment. The company offers solutions in the fields of orthopedics, dermatology, immunology, inflammation, allergy, fungal infections and pain relief. Kaken also offers fungicides, rice herbicides, anti-coccidial for chicken and polypeptide antibiotics. The company conducts research in inflammation and immune disorders, neurological pain relief and fungal infection areas. It markets products through license and distribution agreements with companies in the US, Canada, Taiwan, China, South Korea, Israel and Jordan and operates sales offices in various places in Japan. Kaken is headquartered in Tokyo, Japan.
Headquarters
Japan
Address
20f, Bunkyo Green Court Center Office, 2-28-8, Honkomagome, Bunkyo-Ku, Tokyo, 113-8650
Website
www.kaken.co.jp
Telephone
81 3 59775001
No of Employees
1,130
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
4521 (TYO)
Revenue (2022)
$539.2M
-4%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-43%
(2022 vs 2021)
Market Cap*
$1.0B
Net Profit Margin (2022)
XYZ
-40.7%
(2022 vs 2021)
* As of and is in US$
Kaken Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pharmaceuticals and Medical Devices: | Artz |
| Artz- Anti-Osteoarthritis | Procylin |
| Procylin- Oral-use Prostaglandin | Adofeed |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In March, the company signed an agreement to acquire the rights for vertigo and equilibrium disturbance treatment Merislon and muscle relaxant Myonal in Japan from Eisai Co., Ltd. |
| 2023 | New Products/Services | In August, the company launched NexoBrid in Japan. |
| 2023 | New Products/Services | In May, the company launched “NexoBrid Gel 5g” for the removal of burn eschar. |
Competitor Comparison
| Key Parameters | Kaken Pharmaceutical Co Ltd | Daiichi Sankyo Co Ltd | Eisai Co Ltd | Mitsubishi Tanabe Pharma Corp | Sawai Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Bunkyo-Ku | Chuo-Ku | Bunkyo-Ku | Osaka | Osaka |
| State/Province | Tokyo | Tokyo | Tokyo | Osaka | Osaka |
| No. of Employees | 1,130 | 17,435 | 11,076 | 6,697 | 2,414 |
| Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Hiroyuki Horiuchi | Chief Marketing & Sales Officer; President; Chief Executive Officer; Director | Executive Board | 2020 | 61 |
| Masahiro Matsuura | Director | Senior Management | 2020 | 54 |
| Masashi Suzudo | Director - Business Development Department and Special Assignments; General Manager - Corporate Planning & Coordination Department | Senior Management | 2020 | 61 |
| Yoshio Tanabe | Director - Legal Affairs & Intellectual Property Department and General Affairs Department | Senior Management | 2016 | 68 |
| Minoru Ohta | Director | Senior Management | 2020 | 65 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward